Obstetrics and Gynecology

1046 questions

Question 441Question →

Match each patient's clinical presentation and tumor molecular profile with the most appropriate targeted therapy or management strategy based on current gynecologic oncology guidelines.

Click a left item, then click its matching right item

Items

A 62-year-old woman with stage III high-grade serous ovarian carcinoma in remission after initial platinum-based chemotherapy; somatic tumor testing reveals a pathogenic BRCA1 mutation.
A 68-year-old woman with recurrent, metastatic endometrioid endometrial adenocarcinoma; tumor immunohistochemistry demonstrates loss of MLH1 and PMS2 expression.
A 55-year-old woman with recurrent high-grade serous ovarian carcinoma that progressed during platinum-based chemotherapy; tumor profiling shows high expression of folate receptor-alpha.
A 45-year-old woman with metastatic squamous cell carcinoma of the cervix; tumor testing reveals a Programmed Death Ligand 1 (PD-L1) Combined Positive Score (CPS) of 25.

Matches

Show answer & explanation

Answer

Match the BRCA1-mutated ovarian cancer to PARP inhibitor maintenance, the dMMR endometrial cancer to PD-1 inhibitor monotherapy, the platinum-resistant FR-alpha positive ovarian cancer to an antibody-drug conjugate, and the PD-L1 positive metastatic cervical cancer to combination chemo-immunotherapy plus anti-VEGF.
Each specific gynecologic malignancy scenario relies on a unique biomarker (BRCA, dMMR, FR-alpha, PD-L1) that dictates its corresponding optimal targeted therapy according to the latest standards of care.

Step-by-Step Solution

1
Analyze Patient 1's profile: Stage III high-grade serous ovarian cancer, responsive to platinum, with a BRCA1 mutation.
Identified indication for targeted maintenance therapy exploiting homologous recombination deficiency.
BRCA-mutated ovarian cancers are highly sensitive to PARP inhibitors due to synthetic lethality.
2
Analyze Patient 2's profile: Metastatic endometrial cancer with absent MLH1/PMS2.
Identified mismatch repair deficiency (dMMR).
dMMR tumors predict a strong response to immune checkpoint blockade as monotherapy.
3
Analyze Patient 3's profile: Platinum-resistant ovarian cancer with high folate receptor-alpha expression.
Identified indication for targeted antibody-drug conjugate therapy.
Folate receptor-alpha is directly targeted by mirvetuximab soravtansine in the platinum-resistant setting.
4
Analyze Patient 4's profile: Metastatic cervical cancer with high PD-L1 expression.
Identified indication for systemic combination therapy.
PD-L1 positivity in advanced cervical cancer warrants the addition of a PD-1 inhibitor to standard chemotherapy and anti-VEGF therapy.

Key Concept

Molecular profiling and targeted therapies in advanced gynecologic malignancies
Estimated Time:2m 0s
Question 442Question →

A 26-year-old woman, G1P0, at 38 weeks gestation presents to the labor and delivery triage unit with painful uterine contractions. Her prenatal course has been uncomplicated. Vital signs on admission are temperature 37.0∘C37.0^{\circ}\text{C} (98.6∘F98.6^{\circ}\text{F}), blood pressure 125/80 mmHg, heart rate 92/min, and respiratory rate 18/min. Cervical examination shows 5 cm dilation, 90% effacement, and -1 station. She is admitted and receives epidural analgesia. Thirty minutes later, she complains of sudden dizziness, nausea, and dyspnea, stating "I feel like I cannot breathe." Her blood pressure is now 82/45 mmHg and heart rate is 118/min. The continuous fetal heart rate tracing reveals a baseline of 120/min with minimal variability and recurrent, visually apparent, gradual decreases in the fetal heart rate (onset to nadir ≥\geq 30 seconds) that consistently begin after the peak of each contraction and return to baseline after the contraction ends.

Laboratory studies obtained on admission:
Hemoglobin: 11.2 g/dL
Platelets: 180,000/mm3180,000/\text{mm}^3

Arterial blood gas (room air):
pH: 7.44
PaO2\text{PaO}_2: 104 mmHg
PaCO2\text{PaCO}_2: 29 mmHg
HCO3−\text{HCO}_3^-: 20 mEq/L

Despite the physician's explanation of the fetal tracing, the patient states, "I am terrified of surgery and absolutely refuse any operative deliveries." Which of the following is the most appropriate initial step in management?

Show answer & explanation

Answer: Administer an intravenous fluid bolus and reposition the patient to the left lateral decubitus position

Answer

The most appropriate initial step in management is to administer an intravenous fluid bolus and reposition the patient to the left lateral decubitus position.
The correct answer addresses the primary, acute, and reversible pathophysiology occurring in this patient. Following the placement of epidural analgesia, sympathetic blockade frequently leads to profound vasodilation, decreased venous return, and subsequent maternal hypotension. This drop in blood pressure critically reduces perfusion to the uteroplacental unit, manifesting on the fetal monitor as late decelerations (gradual decreases in fetal heart rate that begin after the peak of a contraction). The first-line treatment for this complication is conservative intrauterine resuscitation. This includes administering a rapid intravenous fluid bolus to expand intravascular volume and repositioning the patient to the left lateral decubitus position to relieve aortocaval compression by the gravid uterus. Both measures maximize maternal cardiac output and restore placental perfusion, often resolving the fetal decelerations completely.

Step-by-Step Solution

1
Analyze the maternal vital signs and clinical presentation.
The patient developed acute hypotension (82/45 mmHg) and tachycardia shortly after receiving epidural analgesia.
Epidural anesthesia causes sympathetic blockade, which leads to profound peripheral vasodilation and decreased venous return, resulting in maternal hypotension.
2
Interpret the fetal heart rate (FHR) tracing.
The FHR tracing demonstrates late decelerations, characterized by gradual decreases that begin after the peak of the contraction.
Late decelerations indicate uteroplacental insufficiency, which in this acute setting is secondary to the maternal hypotension compromising placental blood flow.
3
Evaluate the laboratory values to rule out confounding pathology.
The hemoglobin (11.2 g/dL) and arterial blood gas (pH 7.44, low PaCO2, low HCO3-) are completely normal for a term pregnancy.
Normal pregnancy induces a physiologic dilutional anemia and a progesterone-driven compensated respiratory alkalosis.
4
Determine the initial management step considering the patient's ethical stance.
Initiate intrauterine resuscitation with intravenous fluids and lateral maternal repositioning.
This conservatively addresses the reversible underlying cause of the fetal distress (hypotension) without violating the patient's strict refusal of operative delivery.

Key Concept

Epidural-induced maternal hypotension is a common cause of acute uteroplacental insufficiency and fetal late decelerations, which should initially be managed with intrauterine resuscitation (IV fluids and lateral repositioning).

Alternative Method

If maternal repositioning and intravenous fluid boluses fail to correct the epidural-induced hypotension, the next appropriate pharmacological step is the administration of intravenous vasopressors such as ephedrine or phenylephrine.
Estimated Time:1m 30s
Question 443Question →

A 35-year-old premenopausal woman, gravida 2, para 2, presents to her gynecologist for routine health maintenance. She has no active complaints, and her past medical history is unremarkable. Speculum examination reveals a normal-appearing cervix with no gross lesions. Arrange the following events in the standard sequential clinical pathway, from her initial screening abnormality to the definitive management of high-grade cervical dysplasia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with an ASC-US cytology result, followed by positive reflex hrHPV testing, leading to a colposcopy with biopsy confirming CIN 3, and concluding with a LEEP for definitive treatment.
The algorithm for cervical cancer screening and prevention follows a stepwise approach from screening to definitive diagnosis and subsequent treatment. In a 35-year-old woman, an initial screening cytology showing Atypical Squamous Cells of Undetermined Significance (ASC-US) requires triage to determine the risk of underlying high-grade dysplasia. The preferred triage method is reflex testing for high-risk HPV. If the hrHPV test is positive, the patient's risk for significant dysplasia is elevated, mandating colposcopy for direct visualization and directed biopsies. Once a tissue diagnosis of a high-grade lesion like CIN 3 is confirmed via biopsy, definitive excisional treatment, such as a Loop Electrosurgical Excision Procedure (LEEP), is required to remove the transformation zone and prevent progression to invasive cervical cancer.

Step-by-Step Solution

1
Identify the initial screening abnormality.
The clinical pathway begins with an indeterminate cytology result of ASC-US.
ASC-US requires triage to determine the patient's risk of underlying high-grade dysplasia.
2
Determine the appropriate triage step for ASC-US.
Reflex testing for high-risk HPV.
Current guidelines recommend hrHPV testing to stratify risk; a positive result indicates a higher risk for significant dysplasia and the need for further diagnostic workup.
3
Identify the next diagnostic step following a positive triage result.
Colposcopy with directed biopsies.
Direct visualization and targeted tissue sampling are required to definitively diagnose the presence and severity of cervical dysplasia.
4
Determine the definitive management for the confirmed high-grade lesion.
Excisional procedure such as LEEP.
CIN 3 is a high-grade precancerous lesion with significant malignant potential that must be removed to prevent progression to invasive cervical cancer.

Key Concept

Algorithmic clinical pathway for the evaluation and management of abnormal cervical cancer screening (ASC-US to CIN 3).
Estimated Time:1m 0s
Question 444Question →

Match each patient's clinical presentation with the most likely underlying diagnosis.

Click a left item, then click its matching right item

Items

A 24-year-old woman with irregular menses, acne, and elevated serum testosterone levels.
A 27-year-old woman with amenorrhea, bilateral milky nipple discharge, and a normal thyroid-stimulating hormone level.
A 32-year-old woman with secondary amenorrhea, vaginal dryness, hot flashes, and an elevated follicle-stimulating hormone level.
A 19-year-old elite distance runner with secondary amenorrhea, a body mass index of 16.5 kg/m², and low luteinizing hormone and follicle-stimulating hormone levels.

Matches

Show answer & explanation

Answer

The presentations match as follows: The hyperandrogenic patient has Polycystic ovary syndrome. The patient with galactorrhea has Hyperprolactinemia. The patient with hypoestrogenic symptoms and high FSH has Primary ovarian insufficiency. The elite runner with low BMI and low FSH/LH has Functional hypothalamic amenorrhea.
Each clinical scenario provides classic, pathognomonic features for a distinct etiology of amenorrhea. Polycystic ovary syndrome is characterized by hyperandrogenism and ovulatory dysfunction. Hyperprolactinemia presents with galactorrhea. Primary ovarian insufficiency presents with hypergonadotropic hypogonadism and menopausal symptoms before age 40. Functional hypothalamic amenorrhea presents with hypogonadotropic hypogonadism in the setting of low energy availability.

Step-by-Step Solution

1
Evaluate the 24-year-old with irregular menses and hyperandrogenism.
Matches with Polycystic ovary syndrome.
These represent the core Rotterdam criteria for diagnosing polycystic ovary syndrome.
2
Evaluate the 27-year-old with amenorrhea and galactorrhea.
Matches with Hyperprolactinemia.
Elevated prolactin inhibits hypothalamic GnRH release, causing amenorrhea, and directly stimulates breast tissue, causing galactorrhea.
3
Evaluate the 32-year-old with hot flashes and high follicle-stimulating hormone (FSH).
Matches with Primary ovarian insufficiency.
Premature depletion of ovarian follicles leads to low estrogen (hot flashes) and a loss of negative feedback, thereby increasing FSH.
4
Evaluate the 19-year-old runner with a low BMI and low gonadotropins.
Matches with Functional hypothalamic amenorrhea.
An energy deficit from intense exercise and low body weight suppresses hypothalamic GnRH pulsatility, leading to low FSH and LH.

Key Concept

Differential diagnosis of secondary amenorrhea based on clinical presentation and targeted screening laboratory findings.
Question 445Question →

Match each clinical presentation of a postpartum patient experiencing fever to its most likely underlying diagnosis.

Click a left item, then click its matching right item

Items

A patient develops a fever of 38.6°C (101.5°F), foul-smelling vaginal discharge, and exquisite uterine fundal tenderness on postpartum day 3 following an urgent cesarean delivery.
A breastfeeding patient presents with a fever of 39.0°C (102.2°F), myalgias, and a warm, firm, erythematous, wedge-shaped area on her right breast on postpartum day 21.
A patient exhibits persistent fever spikes and tachycardia on postpartum day 6, despite 72 hours of appropriate intravenous gentamicin and clindamycin therapy, with a benign abdominal examination.
A patient develops fever, worsening lower abdominal pain, and marked erythema, induration, and purulent drainage originating from the margins of her Pfannenstiel incision on postpartum day 5.

Matches

Show answer & explanation

Answer

The presentations map appropriately to their respective localized or systemic diagnoses based on timing and physical examination findings: fundal tenderness indicates endometritis, late unilateral breast erythema indicates mastitis, refractory fever without focal signs indicates septic pelvic thrombophlebitis, and incisional purulence indicates a surgical site infection.
The correct pairings rely on matching the distinct temporal onset and focal physical examination findings to the corresponding postpartum complication. Endometritis presents early with uterine tenderness; mastitis presents later with unilateral breast symptoms; surgical site infections localize to the incision; and septic pelvic thrombophlebitis is a diagnosis of exclusion when fever persists despite broad-spectrum antibiotics.

Step-by-Step Solution

1
Evaluate the timing of the fever relative to the delivery date.
Fevers on days 2-3 often suggest endometritis, days 5-7 suggest a wound infection or septic pelvic thrombophlebitis, and late fevers (weeks 2-4) suggest mastitis.
The temporal onset is a key distinguishing factor in the differential diagnosis of postpartum infections.
2
Identify focal physical examination findings associated with the fever.
Fundal tenderness points to endometritis, unilateral breast erythema points to mastitis, and incisional purulence points to a surgical site infection.
Localizing signs pinpoint the anatomical source of the infection and guide specific management.
3
Assess the patient's response to initial empiric antibiotic therapy.
Refractory fever despite broad-spectrum coverage for endometritis strongly suggests septic pelvic thrombophlebitis or an undrained deep abscess.
Failure of standard therapy requires broadening the differential diagnosis to include complications like venous thrombosis.

Key Concept

The differential diagnosis of postpartum fever relies on recognizing specific temporal patterns and localizing physical examination findings.
Question 446Question →

Match each clinical presentation of an obstetric emergency to the most likely diagnosis.

Click a left item, then click its matching right item

Items

Sudden-onset severe abdominal pain, vaginal bleeding, and frequent late fetal heart rate decelerations at 37 weeks gestation.
Painless, bright red vaginal bleeding without uterine contractions at 36 weeks gestation.
Painless vaginal bleeding and profound fetal bradycardia occurring immediately following artificial rupture of membranes.
Sudden cessation of labor, acute tearing abdominal pain, and loss of fetal station in a patient with a prior cesarean delivery.

Matches

Show answer & explanation

Answer

Sudden-onset severe pain matches with placental abruption; painless bleeding without contractions matches with placenta previa; bleeding and fetal bradycardia immediately after amniotomy matches with vasa previa; and sudden cessation of labor in a scarred uterus matches with uterine rupture.
Each obstetric emergency has a defining clinical signature. Placental abruption is characterized by painful bleeding and fetal distress. Placenta previa is identified by painless bleeding without contractions. Vasa previa involves painless bleeding of fetal origin immediately upon rupture of membranes, causing rapid fetal bradycardia. Uterine rupture is diagnosed by acute tearing pain, cessation of labor, and loss of fetal station in a patient with a prior uterine scar.

Step-by-Step Solution

1
Analyze the presence or absence of pain associated with the vaginal bleeding.
Painful bleeding points toward placental abruption or uterine rupture, whereas painless bleeding suggests placenta previa or vasa previa.
Pain is a primary differentiating factor in third-trimester bleeding etiologies.
2
Evaluate the timing and triggers of the symptoms in relation to fetal heart rate changes.
Profound fetal bradycardia immediately after membrane rupture strongly indicates vasa previa, due to the tearing of aberrant fetal vessels.
Identifying the precipitating event helps isolate the exact etiology.
3
Consider the patient's obstetric history and intrapartum findings.
A history of prior cesarean delivery combined with sudden loss of contractions and fetal station confirms uterine rupture.
Uterine rupture almost exclusively occurs in patients with a scarred uterus and presents with a classic loss of uterine tone during labor.

Key Concept

Differentiating etiologies of third-trimester bleeding and intrapartum emergencies based on classic clinical features.
Question 447Question →

A female patient in her early sixties presents to her primary care provider reporting vaginal spotting that began two weeks ago. She achieved menopause ten years ago and had been entirely asymptomatic since that time. Recently, she has also noted bilateral breast tenderness and a sensation of pelvic fullness. Her past medical history is notable only for well-controlled essential hypertension. Vital signs are within normal limits. On physical examination, her breasts are mildly tender to palpation but lack any discrete nodules, skin changes, or nipple discharge. Bimanual pelvic examination reveals a solid, mobile, palpable left adnexal mass measuring approximately 7 cm in diameter. Pelvic sonography is subsequently performed, confirming a 7.5-cm solid-cystic left ovarian mass and revealing an endometrial stripe thickness of 12 mm. Which of the following is the most appropriate next step in the management of this patient's condition?

Show answer & explanation

Answer: Office-based histologic evaluation of the endometrium

Answer

Office-based histologic evaluation of the endometrium
The patient's presentation of a solid-cystic adnexal mass, postmenopausal bleeding, a thickened endometrial stripe, and breast tenderness is highly suspicious for an estrogen-secreting ovarian neoplasm, most notably an adult granulosa cell tumor. Granulosa cell tumors secrete estradiol, leading to unopposed estrogen exposure. This continuous estrogenic stimulation frequently causes concurrent endometrial hyperplasia or endometrial adenocarcinoma. Therefore, before proceeding to surgical resection of the ovarian mass, an office-based histologic evaluation of the endometrium is the most appropriate next step. Confirming the presence and grade of an underlying endometrial malignancy preoperatively is critical, as it alters the planned surgical approach (e.g., necessitating comprehensive surgical staging including lymphadenectomy rather than just a simple hysterectomy and bilateral salpingo-oophorectomy).

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and imaging findings.
The combination of postmenopausal bleeding, breast tenderness, a thickened endometrial stripe (12 mm), and a complex adnexal mass indicates an estrogen-secreting ovarian neoplasm, most likely an adult granulosa cell tumor.
Granulosa cell tumors are the most common malignant sex cord-stromal tumors and classically present with hyperestrogenism.
2
Evaluate the downstream effects of the suspected pathology.
Unopposed estrogen secretion places the patient at high risk (up to 10%) for concurrent endometrial hyperplasia or adenocarcinoma.
Chronic estrogenic stimulation without progesterone opposition leads to endometrial proliferation and malignant transformation.
3
Determine the most appropriate management sequence.
The endometrium must be sampled histologically before taking the patient to the operating room.
A preoperative diagnosis of endometrial cancer mandates comprehensive surgical staging (e.g., lymph node dissection), which alters the informed consent and surgical plan compared to removing an isolated ovarian mass.

Key Concept

Granulosa cell tumors often secrete high levels of estrogen, leading to a significantly increased risk of concurrent endometrial hyperplasia or adenocarcinoma; therefore, endometrial sampling is required prior to surgical intervention to appropriately plan the surgical staging.
Question 448Question →

A 30-year-old woman, gravida 2, para 2, is evaluated on postoperative day 1 following an uncomplicated scheduled cesarean delivery for a persistent breech presentation. The patient reports mild incisional pain and moderate lower abdominal cramping that worsens significantly when she breastfeeds her newborn. Her temperature is 37.7°C (99.9°F), blood pressure is 112/70 mm Hg, pulse is 82/min, and respirations are 14/min. Physical examination shows a soft abdomen with a clean, dry, and intact surgical incision. The uterine fundus is firm, palpable at the umbilicus, and mildly tender to deep palpation. Vaginal examination reveals moderate dark red bleeding without large clots. Laboratory studies show a leukocyte count of 16,500/mm³. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and routine postpartum care

Answer

Reassurance and routine postpartum care is the correct management because the patient's symptoms and laboratory findings represent normal postpartum physiology.
The correct approach is reassurance and routine postpartum care. The first few days of the puerperium are characterized by profound normal physiologic changes that can sometimes be confused with pathology. Uterine contractions ('afterpains') are common, especially in multiparous women, and are exacerbated by breastfeeding due to nipple stimulation triggering oxytocin release. A low-grade temperature elevation (up to 37.9°C or 100.3°F) is a normal response to tissue trauma and dehydration during delivery. Furthermore, a significantly elevated leukocyte count (up to 20,000-30,000/mm³) is expected due to the stress of delivery. Because this patient's findings are entirely within the bounds of normal postpartum physiology, no further diagnostic or therapeutic steps are indicated.

Step-by-Step Solution

1
Analyze the patient's reported symptoms (cramping exacerbated by breastfeeding and mild incisional pain).
These are identified as normal uterine involution ('afterpains') and expected postoperative incisional pain.
Breastfeeding stimulates oxytocin release from the posterior pituitary, which causes beneficial uterine contractions to prevent hemorrhage.
2
Evaluate the vital signs and laboratory findings (T 37.7°C, WBC 16,500/mm³).
Both findings are determined to be within normal physiologic limits for the early puerperium.
Tissue trauma from delivery causes a mild inflammatory response resulting in low-grade temperatures. Additionally, physiologic leukocytosis (up to 20,000-30,000/mm³) is a normal change in the immediate postpartum period.
3
Determine the appropriate clinical intervention based on the assessment.
Reassurance and routine care are selected.
Because all clinical and laboratory findings align with expected, normal postpartum recovery, diagnostic testing or pharmacological interventions are unnecessary.

Key Concept

Normal postpartum physiological changes include afterpains (cramping during breastfeeding), low-grade temperature elevations (<38.0°C), lochia rubra, and marked leukocytosis; these require only routine care.
Question 449Question →

A 15-year-old girl is brought to the gynecology clinic by her mother for evaluation of absent menses. On physical examination, she is at the 5th percentile for height. She has Tanner stage 1 breast development and normal external female genitalia. Arrange the following steps in the correct chronological order for the standard algorithmic diagnostic evaluation and subsequent workup of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Pelvic ultrasound, followed by serum FSH levels, then karyotype analysis, and finally a transthoracic echocardiogram.
The correct diagnostic algorithm for primary amenorrhea with absent breast development starts with a pelvic ultrasound to confirm the presence of a uterus. Since the uterus is present, serum FSH is measured next to distinguish between central (hypothalamic or pituitary) and peripheral (ovarian) causes. Elevated FSH indicates primary ovarian insufficiency. In this context (especially given the patient's short stature), a karyotype is then performed to diagnose Turner syndrome. Finally, once Turner syndrome is diagnosed, an echocardiogram is essential to screen for life-threatening cardiac defects.

Step-by-Step Solution

1
Determine the presence of female internal anatomy
A pelvic ultrasound is performed first to confirm the presence of a uterus and ovaries.
The anatomical presence or absence of a uterus dictates the two major divergent pathways in the primary amenorrhea algorithm.
2
Evaluate the hypothalamic-pituitary-ovarian axis
Serum FSH is measured.
Since the uterus is present but breast development is absent, FSH distinguishes between central hypogonadism (low or normal FSH) and primary ovarian insufficiency (elevated FSH).
3
Diagnose the underlying etiology of primary ovarian insufficiency
A karyotype analysis is obtained.
Elevated FSH confirms hypergonadotropic hypogonadism, which in a short female strongly suggests a chromosomal anomaly like Turner syndrome (45,X).
4
Screen for associated systemic comorbidities
A transthoracic echocardiogram is ordered.
Once Turner syndrome is genetically confirmed, patients require immediate screening for congenital heart defects, specifically bicuspid aortic valve and coarctation of the aorta.

Key Concept

Evaluation of primary amenorrhea in a patient with absent secondary sexual characteristics involves sequentially confirming the presence of a uterus, measuring FSH to localize the defect, and obtaining a karyotype if primary ovarian insufficiency is identified.
Estimated Time:1m 0s
Question 450Question →

A 46-year-old woman comes to the office to discuss the results of a recent routine Pap test, which was reported as atypical glandular cells (AGC). The patient has no current symptoms. Her menstrual cycles occur regularly every 28 days and last for 4 to 5 days. Her past medical history is significant for hypertension and class I obesity (BMI 32 kg/m2kg/m^2). She has had no prior abnormal Pap tests. Pelvic examination demonstrates a normal-appearing parous cervix with no visible lesions or gross blood. Bimanual examination reveals a mobile, normal-sized uterus with no adnexal masses. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Colposcopy, endocervical sampling, and endometrial biopsy

Answer

Colposcopy, endocervical sampling, and endometrial biopsy
The correct sequence of procedures evaluates both the endocervical and endometrial compartments. Atypical glandular cells (AGC) on cervical cytology carry a significant risk for underlying neoplasia, including cervical adenocarcinoma, endometrial adenocarcinoma, and high-grade squamous lesions. Because these lesions can originate from either the cervix or the endometrium, a thorough evaluation of both areas is required for specific populations. Current guidelines state that all women with AGC should undergo colposcopy with endocervical sampling (curettage). Additionally, because the risk of endometrial pathology increases with age, concurrent endometrial biopsy is mandated for all women ≥\ge 35 years of age. Women <35< 35 years of age also require endometrial biopsy if they have risk factors for endometrial cancer, such as obesity, chronic anovulation, or abnormal uterine bleeding. Given this patient is 46 years old, she must undergo endometrial sampling in addition to colposcopy and endocervical sampling.

Step-by-Step Solution

1
Analyze the patient's presentation and test results
The patient is a 46-year-old asymptomatic woman with a cervical cytology result showing Atypical Glandular Cells (AGC).
Identifying the specific cytologic abnormality is the first step in determining the diagnostic pathway.
2
Recall the potential origins and risks of AGC
AGC can originate from the endocervix or the endometrium, indicating a higher risk of cervical or endometrial adenocarcinoma compared to squamous cell abnormalities.
Understanding the pathophysiology explains why broad tissue sampling is required.
3
Apply the diagnostic algorithm based on the patient's age and risk factors
All women with AGC require colposcopy and endocervical sampling. Furthermore, women age 35 or older require concurrent endometrial biopsy.
Age is the primary determinant for adding endometrial sampling to the evaluation of AGC.
4
Determine the definitive next step for this specific patient
Since the patient is 46 years old, she unequivocally must undergo evaluation of both the cervix (colposcopy + endocervical sampling) and the endometrium (endometrial biopsy).
This comprehensively rules out malignancies from both potential origins of the atypical glandular cells.

Key Concept

Women aged 35 years or older with atypical glandular cells (AGC) on Pap testing require colposcopy, endocervical sampling, and endometrial biopsy to rule out both cervical and endometrial malignancies.
Estimated Time:1m 0s
Question 451Question →

During a wellness examination, a 28-year-old female reports intense vaginal itching and a change in her vaginal discharge that began five days ago. She recently completed a 10-day course of amoxicillin-clavulanate for acute bacterial sinusitis. Her vital signs are within normal limits. Speculum examination reveals a normal-appearing cervix, marked vulvar erythema, and a thick, curd-like white vaginal discharge that adheres to the vaginal walls. The vaginal pH is 4.2. Which of the following is the most appropriate pharmacotherapy for this patient's current condition?

Show answer & explanation

Answer: Oral fluconazole

Answer

Oral fluconazole
The patient's clinical presentation of intense pruritus, vulvar erythema, and a thick, curd-like (cottage cheese) white discharge, combined with a normal vaginal pH (3.8-4.5), is highly characteristic of vulvovaginal candidiasis. The recent use of broad-spectrum antibiotics (amoxicillin-clavulanate) is a classic risk factor because it alters the normal vaginal flora, allowing Candida species to overgrow. The most appropriate first-line treatment is an antifungal agent such as oral fluconazole.

Step-by-Step Solution

1
Identify the clinical syndrome based on symptoms and physical exam findings
The patient has vulvar pruritus, erythema, and thick, curd-like white discharge with a normal vaginal pH of 4.2.
These are the classic features of vulvovaginal candidiasis.
2
Identify predisposing risk factors
The patient recently completed a course of broad-spectrum antibiotics (amoxicillin-clavulanate).
Antibiotics disrupt normal vaginal lactobacilli, promoting the overgrowth of Candida species.
3
Determine the most appropriate pharmacotherapy
An azole antifungal such as oral fluconazole is the indicated treatment.
First-line therapy for uncomplicated vulvovaginal candidiasis is a targeted oral or topical antifungal.

Key Concept

Vulvovaginal candidiasis classically presents with severe pruritus, a thick white curd-like discharge, and a normal vaginal pH (3.8-4.5). It frequently occurs following antibiotic use and is treated with an azole antifungal like oral fluconazole.
Question 452Question →

A 2727-year-old female presents to the gynecology clinic for contraceptive counseling. She reports that she has not had a menstrual period for the past 77 months. Previously, her menses were regular. Over the last 33 months, she has noticed rapidly increasing coarse facial hair, worsening acne, and a deepening of her voice. She has a history of bipolar disorder, which has been well controlled on valproic acid for the past 22 years. She and her partner do not desire pregnancy, and she requests a reliable form of contraception to start immediately.

Vital signs are:
Temperature: 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F})
Blood pressure: 118/76 mmHg118/76\text{ mmHg}
Pulse: 78/min78\text{/min}
BMI: 28 kg/m228\text{ kg/m}^2

Physical examination reveals coarse hair on her upper lip, chin, and chest. Temporal balding and clitoromegaly are clearly present. Pelvic examination is otherwise unremarkable.

Laboratory studies show:

Laboratory TestPatient ResultReference Range
Urine β\beta-hCGNegative-
Thyroid-stimulating hormone (TSH)0.3 \muU/mL0.3\text{ \mu U/mL}0.5−5.0 \muU/mL0.5 - 5.0\text{ \mu U/mL}
Free thyroxine (T4)0.6 ng/dL0.6\text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7\text{ ng/dL}
Prolactin12 ng/mL12\text{ ng/mL}<25 ng/mL< 25\text{ ng/mL}

Pelvic ultrasonography demonstrates normal-sized ovaries with multiple small, peripherally arranged cysts bilaterally.

Before initiating a contraceptive method, which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels

Answer

The correct answer is the measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels.
The most appropriate next step in management is the measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels. This patient presents with secondary amenorrhea and rapid-onset virilization, evidenced by clitoromegaly, temporal balding, and voice deepening occurring over just 3 months. While she is requesting a reliable form of contraception and her ultrasound shows polycystic-appearing ovaries, rapid virilization is a major red flag for an androgen-secreting tumor of the ovary (e.g., Sertoli-Leydig cell tumor) or adrenal gland. The WHO Medical Eligibility Criteria dictate that unexplained menstrual abnormalities and suspected underlying pathologies must be evaluated prior to initiating hormonal contraception. Measuring testosterone and DHEAS is the critical first step to identify the source of the excess androgens before any symptomatic treatment is given.

Step-by-Step Solution

1
Identify the primary clinical problem and red flag symptoms.
The patient has secondary amenorrhea and desires contraception, but crucially, she exhibits rapid-onset virilization (clitoromegaly, deepening voice, temporal balding) over just 3 months.
Distinguishing between simple hyperandrogenism (hirsutism, acne) and true virilization is critical, as rapid virilization is highly suspicious for a malignant androgen-secreting tumor.
2
Evaluate the proposed management strategies against the clinical presentation.
Although the patient requests contraception and has ultrasound findings resembling polycystic ovary syndrome (PCOS), her severe symptoms cannot be solely attributed to PCOS or valproic acid use.
An androgen-secreting tumor must be ruled out before initiating any treatments (such as combined oral contraceptives) that could delay diagnosis by artificially inducing withdrawal bleeds and masking symptoms.
3
Determine the most appropriate diagnostic test for the suspected etiology.
Measurement of serum testosterone and DHEAS is indicated as the immediate next step.
These tests differentiate between an ovarian tumor (which typically secretes markedly elevated testosterone) and an adrenal tumor (which typically secretes markedly elevated DHEAS), guiding subsequent targeted imaging.
4
Rule out other distractors based on laboratory findings.
The low free T4 is accompanied by a low TSH.
This indicates a central process or euthyroid sick syndrome (potentially due to cortisol co-secretion from an adrenal tumor), rather than primary hypothyroidism. Initiating levothyroxine is inappropriate without further evaluation of the pituitary-adrenal axis.

Key Concept

In patients presenting for contraception or menstrual irregularities with rapid-onset virilization, an androgen-secreting tumor must be ruled out with serum testosterone and DHEAS levels before initiating any hormonal therapies.
Estimated Time:2m 0s
Question 453Question →

Presenting for a family planning consultation, a 38-year-old gravida 2 para 2 is seeking a reliable method of birth control. She is currently sexually active with a new male partner. Review of her medical chart shows no chronic medical conditions, and she takes no daily medications. Social history is significant for a 20-pack-year smoking habit; she currently smokes approximately one and a half packs of cigarettes per day. She consumes alcohol occasionally on weekends. Today, her blood pressure is 116/74 mmHg, pulse is 76/min, and BMI is 24 kg/m². Cardiopulmonary and abdominal examinations are within normal limits. A pelvic exam shows a normal-appearing cervix without discharge, and a point-of-care urine beta-hCG test is negative. Which of the following contraceptive options is absolutely contraindicated for this patient?

Show answer & explanation

Answer: Ethinyl estradiol and norgestimate oral tablet

Answer

Ethinyl estradiol and norgestimate oral tablet
Combined hormonal contraceptives, such as the ethinyl estradiol and norgestimate oral tablet, are absolutely contraindicated in patients who are 35 years of age or older and smoke 15 or more cigarettes daily. The combination of estrogen and heavy smoking at this age synergistically increases the risk of arterial thrombosis, potentially leading to myocardial infarction or ischemic stroke.

Step-by-Step Solution

1
Identify the patient's age and relevant social history.
The patient is 38 years old and smokes 1.5 packs (30 cigarettes) per day.
Age and smoking status are critical variables in determining the safety profile of hormonal contraceptives.
2
Apply the WHO Medical Eligibility Criteria (MEC) for contraceptive use.
Age 35 or older combined with smoking 15 or more cigarettes per day is a Category 4 (absolute) contraindication for estrogen-containing contraceptives.
The synergistic effect of age, smoking, and exogenous estrogen significantly elevates the risk of severe cardiovascular events (e.g., myocardial infarction, stroke, thromboembolism).
3
Evaluate the given contraceptive options for estrogen content.
Only the ethinyl estradiol and norgestimate oral tablet contains estrogen. The others are either progestin-only or non-hormonal.
Progestin-only and non-hormonal methods are generally safe for smokers over the age of 35.

Key Concept

WHO Medical Eligibility Criteria for Combined Hormonal Contraceptives
Question 454Question →

A woman at 40 weeks gestation, gravida 1, para 0, is undergoing labor induction for oligohydramnios. She is 29 years of age. An oxytocin infusion was started six hours ago. She now complains of relentless, overlapping abdominal cramping. Maternal vital signs show a blood pressure of 118/72 mmHg, a heart rate of 84/min, and a temperature of 37.0°C (98.6°F). A review of the tocodynamometer reveals seven uterine contractions in the past ten minutes, lasting up to 90 seconds each. The fetal heart rate tracing demonstrates a baseline of 135/min, minimal variability, and recurrent gradual decreases in heart rate that reach their nadir after the peak of the contractions. Pelvic examination shows the cervix is 5 cm dilated, 80% effaced, and at -1 station. Which of the following is the most appropriate initial intervention?

Show answer & explanation

Answer: Discontinue the oxytocin infusion and assist the patient into a lateral position

Answer

The most appropriate initial intervention is to discontinue the oxytocin infusion and assist the patient into a lateral position.
The patient is experiencing uterine tachysystole, defined as more than 5 contractions in 10 minutes averaged over a 30-minute window. This excessive uterine activity limits the time available for blood to flow through the intervillous space, leading to uteroplacental insufficiency, which manifests as late decelerations and minimal variability on the fetal monitor. The most appropriate initial step in intrauterine resuscitation is to stop the offending agent by discontinuing the oxytocin infusion. Assisting the patient into a lateral position relieves aortocaval compression and improves maternal cardiac output, further maximizing placental perfusion.

Step-by-Step Solution

1
Analyze the fetal heart rate and uterine activity tracing.
The tracing shows more than 5 contractions in 10 minutes (uterine tachysystole) accompanied by minimal variability and late decelerations.
Identifying the primary pathophysiologic problem of uteroplacental insufficiency due to excessive uterine contractions is required to determine the correct management.
2
Determine the immediate intervention for uterine tachysystole with nonreassuring fetal status.
The first step is to discontinue any uterotonic agents (oxytocin) and reposition the patient laterally.
Stopping the exogenous stimulus allows the uterus to relax, while lateral positioning increases venous return and cardiac output, rapidly restoring blood flow to the placenta.

Key Concept

The initial management of uterine tachysystole causing late decelerations is intrauterine resuscitation, which primarily involves discontinuing uterotonic agents and maternal repositioning.
Question 455Question →

Seeking care at a community clinic, a 26-year-old female reports that her menses completely stopped 11 months ago. She additionally describes experiencing sudden episodes of intense body warmth and sweating that frequently awaken her at night, along with new-onset vaginal discomfort during sexual intercourse. Prior to this, her menstrual cycles were regular every 29 days since menarche at age 13. She has no significant past medical history and takes no medications. Her body mass index is 21 kg/m². A urine pregnancy test performed in the office is negative. Which of the following serum hormone profiles is most likely present in this patient?

Show answer & explanation

Answer: Increased follicle-stimulating hormone, decreased estradiol

Answer

Increased follicle-stimulating hormone, decreased estradiol
The patient's presentation of secondary amenorrhea, nocturnal vasomotor symptoms (night sweats/hot flashes), and vaginal atrophy at age 26 is highly characteristic of primary ovarian insufficiency (POI). POI occurs when there is a depletion or dysfunction of ovarian follicles before age 40. Because the follicles are not developing properly, they produce very little estradiol, causing the systemic symptoms of estrogen deficiency. The lack of circulating estradiol and inhibin removes the normal negative feedback on the anterior pituitary gland, which subsequently secretes excessive amounts of follicle-stimulating hormone (FSH) in a futile attempt to stimulate the ovaries. Therefore, the expected laboratory profile is an increased FSH and a decreased estradiol level.

Step-by-Step Solution

1
Analyze the patient's symptoms to determine the primary clinical syndrome.
The patient has secondary amenorrhea, severe hot flashes, and vaginal dryness.
Hot flashes and vaginal dryness (dyspareunia) are hallmark signs of a hypoestrogenic state.
2
Identify the underlying diagnosis based on the patient's age and symptom profile.
The diagnosis is primary ovarian insufficiency (POI).
The cessation of ovarian function and estrogen production before the age of 40 is defined as primary ovarian insufficiency.
3
Determine the expected laboratory feedback loop corresponding to the diagnosis.
Decreased ovarian estradiol output leads to a compensatory increase in pituitary follicle-stimulating hormone (FSH).
Without the negative feedback from ovarian estradiol and inhibin, the anterior pituitary secretes high levels of gonadotropins, specifically FSH, resulting in hypergonadotropic hypogonadism.

Key Concept

Primary Ovarian Insufficiency (Hypergonadotropic Hypogonadism)
Question 456Question →

Following a prolonged second stage of labor, a multipara delivers a macrosomic infant vaginally. Shortly after placental expulsion, she develops massive vaginal hemorrhage. Abdominal examination reveals a flaccid, boggy uterus extending above the umbilicus. Despite aggressive intravenous fluid resuscitation, a continuous high-dose oxytocin infusion, and vigorous fundal massage, the patient remains hypotensive at 88/50 mm Hg and tachycardic at 122/min with ongoing brisk bleeding. Arrange the following interventions in the correct escalating sequence for managing this patient's refractory postpartum hemorrhage, starting with the most appropriate immediate next step and ending with the definitive final resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Carboprost with bimanual compression → Intrauterine balloon tamponade → Uterine compression sutures → Internal iliac artery ligation → Peripartum hysterectomy.
The management of refractory postpartum hemorrhage secondary to uterine atony requires a rapid, stepwise escalation algorithm to minimize morbidity while controlling life-threatening blood loss. When initial therapy (oxytocin and fundal massage) fails, the first escalation is to second-line uterotonics (e.g., carboprost, methylergonovine) along with bimanual uterine compression. If medical management is unsuccessful, the next step is a minimally invasive mechanical intervention using an intrauterine balloon tamponade. Should hemorrhage persist despite the balloon, surgical intervention is mandated. The surgical sequence prioritizes uterus-sparing techniques, typically starting with uterine compression sutures (e.g., B-Lynch). If this fails to achieve hemostasis, stepwise pelvic devascularization, such as bilateral internal iliac artery ligation, is performed. Only when all of these medical, mechanical, and uterus-sparing surgical measures have failed is a definitive peripartum hysterectomy performed as a life-saving measure.

Step-by-Step Solution

1
Administer second-line uterotonic agents (e.g., carboprost) and initiate bimanual compression.
Maximizes pharmacologic and manual stimulation of uterine contraction.
Resolves the majority of atony cases that are refractory to oxytocin without needing invasive procedures.
2
Deploy an intrauterine balloon tamponade.
Applies direct mechanical outward pressure against the bleeding uterine walls.
Acts as a highly effective, minimally invasive mechanical bridge when uterotonics fail, avoiding the morbidity of surgery.
3
Proceed to exploratory laparotomy with uterine compression sutures (e.g., B-Lynch).
Mechanically compresses the uterus via surgical folding and suturing.
The preferred first-line surgical intervention because it is uterus-sparing, rapid, and often effective.
4
Perform pelvic devascularization via internal iliac artery ligation.
Significantly reduces the pulse pressure of arterial blood flowing into the pelvic basin and uterus.
Serves as a final uterus-sparing surgical effort if direct uterine compression sutures fail to achieve hemostasis.
5
Execute a total peripartum hysterectomy.
Definitively removes the source of the hemorrhage.
The absolute last resort to save the patient's life when all other therapies have been exhausted, as it causes permanent sterility.

Key Concept

The management of postpartum hemorrhage follows a strict stepwise escalation from medical therapy (second-line uterotonics) to mechanical therapy (balloon tamponade), to uterus-sparing surgery (compression sutures, devascularization), and finally to definitive surgery (hysterectomy).
Question 457Question →

During a wellness visit, a 67-year-old nulligravid female reports noticing blood on her undergarments over the past three weeks. She notes her last menstrual period occurred at age 51. Her medical history includes type 2 diabetes mellitus, hypertension, and obesity. Her current body mass index is 39 kg/m239 \text{ kg/m}^2. A speculum examination reveals a normal-appearing cervix with no vaginal or vulvar lesions. Transvaginal ultrasonography demonstrates an endometrial stripe thickness of 14 mm14 \text{ mm}. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The correct next step is an endometrial biopsy. This patient presents with postmenopausal bleeding (PMB) and possesses several unopposed estrogen risk factors for endometrial cancer, including obesity, nulligravidity, and type 2 diabetes. The initial evaluation for PMB typically involves either transvaginal ultrasonography or an endometrial biopsy. Because her ultrasound demonstrates an endometrial thickness of 14 mm14 \text{ mm} (normal in postmenopause is ≤4 mm\leq 4 \text{ mm}), she requires immediate histologic evaluation of the endometrium to rule out hyperplasia or carcinoma.

Step-by-Step Solution

1
Identify the patient's primary clinical presentation and risk factors.
The patient has postmenopausal bleeding with multiple risk factors for endometrial cancer, including advanced age, nulligravidity, type 2 diabetes, and obesity.
Recognizing the high-risk profile establishes the pretest probability for endometrial hyperplasia or carcinoma.
2
Evaluate the objective imaging findings provided.
Transvaginal ultrasonography reveals an endometrial thickness of 14 mm.
In postmenopausal women, an endometrial stripe thickness greater than 4 mm is considered abnormal and warrants further investigation.
3
Determine the required diagnostic intervention.
The patient must undergo an endometrial biopsy to obtain a histologic diagnosis.
Tissue sampling is the definitive method to rule out or diagnose endometrial cancer in symptomatic patients with abnormal ultrasound findings.

Key Concept

In postmenopausal women presenting with vaginal bleeding, an endometrial thickness greater than 4 mm4 \text{ mm} on transvaginal ultrasound is abnormal and strictly mandates an immediate endometrial biopsy to rule out malignancy.
Question 458Question →

For each clinical vignette describing a patient with a gynecologic neoplasm, identify the most appropriate definitive surgical intervention or management step.

Click a left item, then click its matching right item

Items

A 29-year-old nulligravid woman undergoes colposcopy-directed biopsy, which reveals cervical squamous cell carcinoma. The depth of stromal invasion is 2 mm, and there is no evidence of lymphovascular space invasion. She wishes to preserve her childbearing potential.
A 67-year-old woman reports increasing early satiety and abdominal girth. A computed tomography scan shows a 10-cm solid and cystic right adnexal mass, moderate ascites, and diffuse omental nodularity. She has no significant medical comorbidities.
A 61-year-old postmenopausal woman with class III obesity is evaluated for abnormal uterine bleeding. Endometrial sampling demonstrates complex atypical hyperplasia, also classified as endometrial intraepithelial neoplasia.
A 72-year-old woman presents with a 2.5-cm, biopsy-confirmed squamous cell carcinoma on the right labium majus. The tumor invades 3 mm into the underlying stroma. The bilateral inguinofemoral regions are clinically free of palpable adenopathy.

Matches

Show answer & explanation

Answer

1 matches with Cervical conization. 2 matches with Exploratory laparotomy with cytoreductive surgery. 3 matches with Total extrafascial hysterectomy. 4 matches with Radical partial vulvectomy.
Each specific surgical intervention accurately aligns with the standardized clinical guidelines (ACOG/SGO) tailored to the respective patient's precise pathology, depth of invasion, menopausal status, and fertility goals.

Step-by-Step Solution

1
Analyze the clinical staging for the young patient with cervical microinvasion.
Identify Stage IA1 squamous cell carcinoma in a nulligravid patient.
Fertility-sparing surgery (cervical conization) is the standard of care for Stage IA1 disease without LVSI, avoiding unnecessary hysterectomy.
2
Evaluate the patient with a large adnexal mass, ascites, and omental nodularity.
Recognize a high suspicion for advanced-stage ovarian cancer.
Maximal cytoreductive debulking via exploratory laparotomy improves chemotherapy efficacy and overall survival in advanced epithelial ovarian cancer.
3
Assess the postmenopausal woman with complex atypical hyperplasia.
Recognize a high-risk precancerous lesion (EIN) with significant potential for concurrent malignancy.
Due to the high risk of occult adenocarcinoma, definitive management requires total extrafascial hysterectomy with bilateral salpingo-oophorectomy.
4
Determine surgical needs for the patient with a 2.5-cm vulvar lesion and 3 mm invasion.
Identify early invasive vulvar squamous cell carcinoma requiring nodal assessment.
Lesions invading >1 mm into the stroma mandate radical partial vulvectomy along with inguinofemoral lymph node evaluation to rule out metastasis.

Key Concept

Surgical management in Gynecologic Oncology is strictly dictated by tumor origin, precise staging criteria (e.g., depth of invasion), patient age, and fertility-sparing considerations.
Estimated Time:2m 0s
Question 459Question →

A 22-year-old nulligravid woman is evaluated in an urgent care center due to a two-day history of worsening, bilateral lower pelvic discomfort and an abnormal, yellowish vaginal discharge. She reports no nausea, emesis, or fever. Her vital signs are stable. Arrange the following actions in the most appropriate chronological sequence for the standard diagnostic workup and outpatient management of this patient's suspected pelvic inflammatory disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first rule out ectopic pregnancy with a urine pregnancy test, establish a clinical diagnosis via bimanual pelvic examination, collect appropriate microbiological swabs during the exam, promptly initiate empiric broad-spectrum antimicrobial therapy, and finally arrange for a 48 to 72 hour clinical follow-up.
The standard of care for a reproductive-aged female presenting with lower abdominal pain involves a sequential, safety-first approach. A pregnancy test is mandatory to rule out ectopic pregnancy. Next, a bimanual examination establishes the clinical criteria for PID. During this exam, specimens are collected for NAAT. Because delaying treatment increases the risk of infertility, broad-spectrum antibiotics are administered immediately after sampling. Finally, because outpatient therapy can fail, a 48 to 72 hour follow-up is scheduled at discharge.

Step-by-Step Solution

1
Obtain a point-of-care urine pregnancy test
Rules out ectopic pregnancy
Lower abdominal pain in a reproductive-aged female requires immediate exclusion of life-threatening obstetric emergencies.
2
Perform a bimanual pelvic examination
Establishes the clinical diagnosis
Cervical motion, uterine, or adnexal tenderness on physical exam is required to clinically diagnose uncomplicated pelvic inflammatory disease.
3
Collect endocervical swabs for NAAT
Provides targeted identification of the etiologic pathogen
Specimens must be collected during the pelvic examination and prior to starting antibiotics to ensure accurate microbiological testing.
4
Initiate empiric broad-spectrum antimicrobial therapy
Provides immediate treatment for the most likely pathogens
Treatment should not be delayed while awaiting NAAT results to prevent long-term sequelae such as tubal scarring and infertility.
5
Schedule a clinical reevaluation in 48 to 72 hours
Ensures the outpatient treatment is effective
Patients with PID require close monitoring; failure to improve within 72 hours necessitates hospitalization and parenteral therapy.

Key Concept

Sequential diagnostic and therapeutic approach to uncomplicated pelvic inflammatory disease in the outpatient setting.
Estimated Time:1m 0s
Question 460Question →

Match each clinical presentation of a suspected gynecologic infection with its most likely diagnosis and corresponding management strategy.

Click a left item, then click its matching right item

Items

A patient presents with a malodorous, frothy, yellow-green vaginal discharge. Pelvic examination reveals punctate macular hemorrhages on the cervix. Vaginal pH is measured at 6.0.
A patient reports an off-white, thin, homogeneous vaginal discharge with a noticeable amine odor after intercourse. Wet mount microscopy reveals vaginal epithelial cells with stippled, indistinct margins.
A patient complains of intense vulvovaginal pruritus. Examination shows marked vulvar erythema and a thick, clumpy, white, adherent vaginal discharge. Vaginal pH is 4.0.
A patient is evaluated for new-onset postcoital spotting. Speculum examination reveals a friable cervix with a mucopurulent exudate visible at the external os. Vaginal pH is 4.2.

Matches

Show answer & explanation

Answer

The clinical presentations correctly pair with their diagnoses and management based on pH, discharge qualities, and microscopic findings: the frothy discharge with elevated pH matches Trichomonas; the clue cells and amine odor match Bacterial Vaginosis; the clumpy discharge with normal pH matches Candida; and the friable cervix with mucopurulent discharge matches Endocervicitis.
Each clinical vignette provides classic hallmark findings for a specific gynecologic infection, allowing for precise pairing with the etiologic agent. Furthermore, recognizing whether the infection is a dysbiosis (like bacterial vaginosis or candidiasis) versus a sexually transmitted infection (like trichomoniasis or chlamydial cervicitis) is critical for determining whether partner treatment is required.

Step-by-Step Solution

1
Evaluate the clinical findings in the first presentation.
Identified frothy yellow-green discharge, punctate cervical hemorrhages, and pH of 6.0.
These are the classic signs of Trichomonas vaginalis, which dictates systemic treatment for both the patient and sexual partners.
2
Evaluate the clinical findings in the second presentation.
Identified thin homogeneous discharge, positive amine odor, and clue cells.
These fulfill Amsel criteria for bacterial vaginosis. Because BV is a dysbiosis and not a classic STI, partner treatment is not recommended.
3
Evaluate the clinical findings in the third presentation.
Identified intense pruritus, thick clumpy discharge, and a normal pH of 4.0.
A normal pH (<4.5) in the setting of vulvar erythema and cottage cheese-like discharge is diagnostic of vulvovaginal candidiasis, requiring antifungal therapy.
4
Evaluate the clinical findings in the fourth presentation.
Identified postcoital spotting, friable cervix, mucopurulent exudate, and normal vaginal pH.
These findings localize the infection to the cervix rather than the vagina. Endocervicitis (commonly due to Chlamydia trachomatis) requires targeted antibiotic therapy and partner treatment.

Key Concept

Diagnosis and management of common gynecologic infections (vaginitis and cervicitis) based on clinical presentation, vaginal pH, microscopy, and partner treatment requirements.
PreviousPage 23 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 23 | Examkin